From Emerging Markets, For Emerging Markets

---

At RevonBio, we believe that impactful partnerships drive the success of ecosystems. That’s why we are selective about who we work with. We don’t work with everyone — we partner with those who align with our vision of creating sustainable healthcare solutions for underserved regions.

Our approach ensures that every partnership is built on shared goals, accountability, and measurable success.

We choose biotechs that have the vision, readiness, and ability to expand their reach beyond their home market.

Criteria for Biotechs:

1. Regulatory Readiness: Products that are already registered or nearing registration in their country of origin.
2. Commitment to Quality: Adherence to GMP standards and proven ability to scale production.
3. Alignment with Market Needs: Therapies that address critical gaps in emerging markets, such as vaccines, biosimilars, and specialty medicines.
4. Innovation and Passion: A proven commitment to delivering innovative therapies and addressing unmet healthcare needs.

What We Offer Biotechs:

• Unlock new markets with tailored strategies and regulatory expertise.
• Build strong distribution networks with exclusive agreements.
• Expand impact and profitability while maintaining affordability.

Example Partner: A biotech with a biosimilar insulin ready for launch in Eurasia, seeking guidance on scaling distribution and navigating regulatory pathways.

We work with distributors that demonstrate a strong commitment to excellence, a deep understanding of their market, and the operational capacity to scale.

Criteria for Distributors:

1. Regional Reach: Established networks and infrastructure to serve key territories.
2. Compliance and Accountability: Proven track record of adhering to distribution agreements and regulatory standards.
3. Sales and Forecasting Accuracy: Ability to meet demand reliably and maintain strong cash flow.
4. Strategic Alignment: A passion for introducing innovative therapies and expanding access in underserved regions.

What We Offer Distributors:

• Exclusive access to innovative, high-demand therapies.
• Co-marketing opportunities and specialized training programs.
• Support with forecasting, operational scaling, and market activation.

Example Partner: A distributor in LATAM with expertise in oncology therapies, seeking access to cost-effective biosimilars to meet rising demand.

We partner with CDMOs that are prepared to optimize their capacity and align their manufacturing capabilities with market-ready products.

Criteria for CDMOs:

1. Capacity for Scale: Facilities with available capacity and expertise in large-scale production.
2. Compliance Excellence: Proven GMP compliance and alignment with international regulatory standards.
3. Commitment to Quality: A track record of delivering high-quality manufacturing outputs.
4. Growth Mindset: CDMOs that are ready to build long-term, consistent demand pipelines.

What We Offer CDMOs:

• Matchmaking with biotechs that align with your expertise and capabilities.
• Long-term production partnerships with steady demand.
• Guidance on GMP compliance and operational optimization.

Example Partner: A CDMO specializing in plasma-derived therapies seeking to expand into new markets by partnering with biotechs producing immunoglobulins and clotting factors.